Hokko Chemical Industry (4992) Q2 2026 earnings summary

Executive summary

• Revenue for the first half of FY2026 rose 7.1% year-over-year to ¥32,849 million, driven by strong sales in the agrochemical segment.

• Operating income increased 14.4% to ¥4,184 million, and net income attributable to shareholders grew 20.7% to ¥3,380 million, aided by higher sales and investment gains.

• The company continues to execute its three-year management plan, focusing on strengthening its earnings and production base, with growth investments and reforms in profitability, manufacturing, and work style.

Financial highlights

• Revenue: ¥32,849 million (up 7.1% year-over-year).

• Operating income: ¥4,184 million (up 14.4% year-over-year).

• Ordinary income: ¥4,657 million (up 17.6% year-over-year), boosted by foreign exchange gains.

• Net income attributable to shareholders: ¥3,380 million (up 20.7% year-over-year), including gains from the sale of investment securities.

• EPS for the half-year: ¥131.10 (up from ¥106.18 year-over-year).

Outlook and guidance

• Full-year revenue forecast: ¥52,000 million (up 5.9% year-over-year).

• Full-year operating income forecast: ¥5,200 million (up 5.8% year-over-year).

• Full-year net income forecast: ¥4,460 million (up 0.2% year-over-year).

• No changes to previously announced guidance.